We initiated this study, with the aim of evaluating the mRNA expression patterns of VEGF family members in high-risk early breast cancer patients who had participated in a large randomized adjuvant chemo-hormonotherapy trial. The gene discussed is VEGFA; the disease is breast carcinoma.